Ependymal Tumor

subtype

Identifier: CI-CAN-00002591
Entity page: /cancer/ependymal-tumor ↗
Edges: 215

Neighbours: 64 drugs10 trials
Drawn: 60 of 74 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Ependymal Tumor investigated in trials for …INVESTIGATED_IN_TRIALSderived64 of 64show fewer
→ investigated in trials for	Temozolomidesmall molecule 15 trials (3 active) · roll-up of the cancer and its descendants	—	—	Ependymal Tumor	15	Observed	clinicaltrials	graph →
→ investigated in trials for	Bevacizumabmonoclonal antibody 7 trials (2 active) · roll-up of the cancer and its descendants

Ependymal Tumor studied in …STUDIED_INderived10 of 151show all (up to 200)
→ studied in	NCT01445288completed Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active)	—	—	Ependymoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07031765Phase 1 · active not recruiting Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active)	—	—	Ependymoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 151 trials mapped (50 active)	—	—	Childhood Ependymoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03251989completed Rare CNS Tumors Outcomes &Risk · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active)	—	—	Ependymoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03698994Phase 2 · active not recruiting Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 151 trials mapped (50 active)	—	—	Ependymal Tumor	1	Observed	clinicaltrials	graph →
→ studied in	NCT06804655Phase 2 · recruiting Pharmacoscopy for Patients With Refractory Primary Brain Tumors · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active)	—	—	Ependymoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06639607Phase 1/Phase 2 · suspended PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active)	—	—	Ependymoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07061626Phase 1 · recruiting Determine Maximum Tolerated Dose, Safety, and Tolerability of Rhenium (186Re) in Pediatric Recurrent, Refractory or Progressive Ependymoma and High-Grade Glioma · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active)	—	—	Ependymoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT07390539Phase 1 · recruiting B7-H3.CD28Z.CART in CNS Neoplasms · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active)	—	—	Ependymoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT04374305Phase 2 · recruiting Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2) · condition mapped ONTOLOGY_EXACT · 151 trials mapped (50 active)	—	—	Ependymoma	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains